Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Nov/14/2020 Nov/27/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Hesperidin Potential treatment - theoretical effect Natural product Antiviral Oct/27/2020 Nov/24/2020 0
Lupinifolin Potential treatment - theoretical effect Natural product Antiviral Oct/21/2020 Nov/24/2020 0
VH2 A01-B02 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0
VH3 B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0
VH2 A01-B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0
SARS-CoV-2 HRC lipopeptide Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0
VHH-Fcs 1B-3F-2A Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0
VHH-Fcs 3F-1B-2A Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 Nov/24/2020 0